WHO suggests using survivors' blood to treat Ebola

The World Health Organization has issued new recommendations, which state that doctors should use the blood of Ebola survivors to treat Ebola patients.

At a press conference Friday, WHO expert Dr. Marie Paule Kieny said that the antibodies in survivors' blood could help treat Ebola, and doctors should use all possible methods to stop Ebola's largest-ever outbreak.

The blood of survivors was one of the experimental Ebola treatments tested at a meeting of more than 200 experts in Geneva this week. The doctors noted that using the survivors' blood is "fairly simple" to do in comparison to other experimental treatments. In addition to the blood proposal, the WHO also announced that it is testing a potential new Ebola vaccine in the U.S.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Sign up

The WHO estimated that survivor blood may be available for Ebola treatment by the end of the year. Ebola has infected more than 2,100 people so far, with a nearly 50 percent death rate.